Pheumatosis cystoides intestinalis after α-glucosidase inhibitor treatment in a patient with interstitial pneumonitis

31Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A 56-year-old woman was admitted to our hospital for treatment of non-specific interstitial pneumonitis (NSIP). The patient started prednisone treatment, but one month later treatment with voglibose, an α-glucosidase inhibitor (α-GI), was started because of prednisone-induced diabetes mellitus. One week later, a massive volume of free air below the diaphragm was detected by a chest X-ray examination. An abdominal CT examination demonstrated pneumatosis coli and the patient was diagnosed with pneumatosis cystoides intestinalis (PCI). Voglibose was discontinued and parenteral nutrition and oxygen inhalation were initiated. Radiographic findings of PCI disappeared within 7 days. We encountered a rare case of PCI, that was associated with α-GI treatment. © 2006 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Hisamoto, A., Mizushima, T., Sato, K., Haruta, Y., Tanimoto, Y., Tanimoto, M., & Matsuo, K. (2006). Pheumatosis cystoides intestinalis after α-glucosidase inhibitor treatment in a patient with interstitial pneumonitis. Internal Medicine, 45(2), 73–76. https://doi.org/10.2169/internalmedicine.45.1330

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free